Free Biopharma Stock Content

$XBI $105.23 -5.50% % Covid Updates $NRXP +3.0% NRx Pharmaceuticals Submits Emergency Use Authorization Application to US Food and Drug...

$XBI $111.36 -3.53% % Covid Updates $GRTS -42.4% Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study...

$XBI $115.44 +3.11% % Covid Updates $MRNA -7.5% Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of...

$XBI $111.96 | -1.13%% Covid Updates $VIR Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...

$XBI $113.24 +0.44%% Covid Updates $OCGN +10.3% Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From...

$XBI $112.74 -0.4%% Covid Updates $ORMD +0.9% Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial...

$XBI $112.74 -0.4%% Covid Updates $ORMD +0.9% Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial...

$XBI $113.21 -1.7%% Covid Updates $DVAX -1.3% COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant Receives India...

$XBI $115.17 -2.6%% Covid Updates $MRNA -1.2% Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional...

$XBI $118.22 +1.46%% Covid Updates $PFE -1.4% & $BNTX -1.7% Pfizer and BioNTech Submit Updated Longer-Term Follow-Up Data of COMIRNATY®...

$XBI $116.52 -0.1%% Covid Updates $GILD +0.8% Gilead Announces New England Journal of Medicine Publication of Data Demonstrating...

$XBI $116.58 +0.68%% Covid Updates $NVAX -5.4% Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study...

$XBI $115.79 +0.16%% Covid Updates $NVAX -7.1% World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19...

$XBI $115.61 +4.78%% Covid Updates $GSK Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early...

$XBI $110.34 -2.7%% Covid Updates $AXLA +0.4% Axcella Therapeutics Announces Initiation of AXA1125 Long COVID Phase 2a Clinical Trial...

$XBI $113.39 +4.25%% Covid Updates $CDXS +2.4% Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in...

$XBI $108.77 -1.83%% Covid Updates $ORMP -6.8% Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19...

$XBI $110.80 +0.81%% Covid Updates $ Pipeline Updates $SRRA -2.0% Sierra Oncology Reports Baseline Ferritin Differentially Predicts Week...

(First posted 12/13/21) Want to get Catalyst Events and stocks to watch sent directly to your inbox each week? sign up for our free...